These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin. Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA. Cancer Res; 1992 Oct 15; 52(20):5674-80. PubMed ID: 1327513 [Abstract] [Full Text] [Related]
3. Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin. Twentyman PR, Wright KA, Rhodes T. Int J Radiat Oncol Biol Phys; 1991 Feb 15; 20(2):217-20. PubMed ID: 1846846 [Abstract] [Full Text] [Related]
4. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line. Cole SP, Downes HF, Mirski SE, Clements DJ. Mol Pharmacol; 1990 Feb 15; 37(2):192-7. PubMed ID: 1968221 [Abstract] [Full Text] [Related]
5. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL, Hwang J, Perng RP, Whang-Peng J. Oncol Res; 1995 Feb 15; 7(1):31-8. PubMed ID: 7549042 [Abstract] [Full Text] [Related]
9. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N. Cancer Res; 1991 Jun 15; 51(12):3237-42. PubMed ID: 1645616 [Abstract] [Full Text] [Related]
11. Modulation of doxorubicin cytotoxicity by ethacrynic acid. Awasthi S, Singhal SS, He N, Chaubey M, Zimniak P, Srivastava SK, Singh SV, Awasthi YC. Int J Cancer; 1996 Nov 04; 68(3):333-9. PubMed ID: 8903475 [Abstract] [Full Text] [Related]
12. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines. Robson C, Wright KA, Twentyman PR, Lambert PA, Griffin RJ. Biochem Pharmacol; 1998 Oct 01; 56(7):807-16. PubMed ID: 9774142 [Abstract] [Full Text] [Related]
13. Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel. Su GM, Davey MW, Davey RA. Int J Cancer; 1998 May 29; 76(5):702-8. PubMed ID: 9610729 [Abstract] [Full Text] [Related]
14. Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines. Shellard SA, Fichtinger-Schepman AM, Lazo JS, Hill BT. Anticancer Drugs; 1993 Aug 29; 4(4):491-500. PubMed ID: 8400352 [Abstract] [Full Text] [Related]
15. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH, Gupta V, Singh SV. Arch Biochem Biophys; 1994 Jan 29; 308(1):164-70. PubMed ID: 8311448 [Abstract] [Full Text] [Related]
16. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines. Lee YS, Nishio K, Ogasawara H, Funayama Y, Ohira T, Saijo N. Cancer Res; 1995 Mar 01; 55(5):1075-9. PubMed ID: 7866991 [Abstract] [Full Text] [Related]
18. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. Br J Cancer; 1991 Aug 01; 64(2):215-20. PubMed ID: 1892748 [Abstract] [Full Text] [Related]
19. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. Twentyman PR, Fox NE, Wright KA, Bleehen NM. Br J Cancer; 1986 Apr 01; 53(4):529-37. PubMed ID: 3011054 [Abstract] [Full Text] [Related]